Matches in Wikidata for { <http://www.wikidata.org/entity/Q94138807> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q94138807 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94138807 description "wetenschappelijk artikel" @default.
- Q94138807 description "наукова стаття, опублікована в жовтні 2019" @default.
- Q94138807 name "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 name "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 type Item @default.
- Q94138807 label "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 label "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 prefLabel "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 prefLabel "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 P1433 Q94138807-BBF18972-67DB-4797-8244-3DC8EE9E81F8 @default.
- Q94138807 P1476 Q94138807-3F4B52FA-50CE-4F1C-B702-47CBC9C34EB7 @default.
- Q94138807 P2093 Q94138807-05AF3CEF-CA39-4CF4-B29C-6C427484F958 @default.
- Q94138807 P2093 Q94138807-0E7F79AB-246F-4523-817E-E53D33EF06D4 @default.
- Q94138807 P2093 Q94138807-19EB6B4A-EAD6-48E9-978A-215C248953F9 @default.
- Q94138807 P2093 Q94138807-58B95C38-6E77-4CD1-A44E-66DAA8752E1A @default.
- Q94138807 P2093 Q94138807-6CA7CACD-9EBA-4524-A551-641519FED040 @default.
- Q94138807 P2093 Q94138807-753B65AD-098B-447F-B788-42977EA73917 @default.
- Q94138807 P2093 Q94138807-87F01955-11F6-41F5-95A7-96D55DFDC7FA @default.
- Q94138807 P2093 Q94138807-C1EAD977-E548-4C91-AF34-AB3C84E78807 @default.
- Q94138807 P2093 Q94138807-CCDBF85B-2078-407F-AC03-55765110516C @default.
- Q94138807 P2093 Q94138807-D6B9F294-AA1B-465B-8DB3-66C8B7C8D00A @default.
- Q94138807 P275 Q94138807-9faee25f-f09c-4d47-8f61-3bf9cf4a139c @default.
- Q94138807 P304 Q94138807-92513565-7724-4851-9D72-6FD2F9A429B6 @default.
- Q94138807 P31 Q94138807-06343FF6-2051-4968-A5D6-36CF92EB10E5 @default.
- Q94138807 P356 Q94138807-02DDEA97-52A0-452D-AA75-8618B4ADFE75 @default.
- Q94138807 P433 Q94138807-02D3646E-E94E-4331-A573-C646397AD5B8 @default.
- Q94138807 P478 Q94138807-CB0BD489-2DEE-4EAF-9DC0-0EEE411CAAA5 @default.
- Q94138807 P50 Q94138807-05344A91-36EC-436F-BA1C-C74AE4525C3B @default.
- Q94138807 P50 Q94138807-2E3C5F98-5ECB-488C-8C5E-B5DB4CB7106B @default.
- Q94138807 P577 Q94138807-AAB0D599-3A15-43D1-A50D-AD026E666109 @default.
- Q94138807 P6216 Q94138807-c2aca7d4-3a87-46e9-9abd-4269cb7372bb @default.
- Q94138807 P921 Q94138807-A46F4645-66B9-40A3-A1AF-C877833A32B1 @default.
- Q94138807 P932 Q94138807-FF26B34F-9167-4F4F-8B1C-7431C8512D70 @default.
- Q94138807 P356 OFZ360.1904 @default.
- Q94138807 P1433 Q27725953 @default.
- Q94138807 P1476 "2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP)" @default.
- Q94138807 P2093 "Brian Yu" @default.
- Q94138807 P2093 "Christopher Bruno" @default.
- Q94138807 P2093 "Dominik Wolf" @default.
- Q94138807 P2093 "Elizabeth G Rhee" @default.
- Q94138807 P2093 "Erin Jensen" @default.
- Q94138807 P2093 "Ignacio Martin-Loeches" @default.
- Q94138807 P2093 "Jennifer A Huntington" @default.
- Q94138807 P2093 "Joan R Butterton" @default.
- Q94138807 P2093 "Linping Li" @default.
- Q94138807 P2093 "Marin Kollef" @default.
- Q94138807 P275 Q24082749 @default.
- Q94138807 P304 "S760-S760" @default.
- Q94138807 P31 Q13442814 @default.
- Q94138807 P356 "10.1093/OFID/OFZ360.1904" @default.
- Q94138807 P433 "Suppl 2" @default.
- Q94138807 P478 "6" @default.
- Q94138807 P50 Q38323212 @default.
- Q94138807 P50 Q42224036 @default.
- Q94138807 P577 "2019-10-23T00:00:00Z" @default.
- Q94138807 P6216 Q50423863 @default.
- Q94138807 P921 Q421670 @default.
- Q94138807 P932 "6810350" @default.